No Data
No Data
AVITA Medical to Announce First Quarter 2025 Financial Results
AVITA Medical to Present Breakthrough Clinical Data in Burn and Wound Care at ABA 2025
Avita Medical's Cohealyx Wound Treatment Makes Commercial Launch in US; Shares Down 4%
AVITA Medical Launches Cohealyx, Supporting Healing and Unlocking New Market Opportunity
Express News | D. Boral Capital Maintains Buy on AVITA Medical, Maintains $22 Price Target
Healthcare Up as Traders Rotate to Less Inflation-Sensitive Sectors -- Health Care Roundup